Literature DB >> 29429104

Molecular Modeling of Chemoreceptor:Ligand Interactions.

Asuka A Orr1, Arul Jayaraman1, Phanourios Tamamis2.   

Abstract

Docking algorithms have been widely used to elucidate ligand:receptor interactions that are important in biological function. Here, we introduce an in-house developed docking-refinement protocol that combines the following innovative features. (1) The use of multiple short molecular dynamics (MD) docking simulations, with residues within the binding pocket of the receptor unconstrained, so that the binding modes of the ligand in the binding pocket may be exhaustively examined. (2) The initial positioning of the ligand within the binding pocket based on complementary shape, and the use of both harmonic and quartic spherical potentials to constrain the ligand in the binding pocket during multiple short docking simulations. (3) The selection of the most probable binding modes generated by the short docking simulations using interaction energy calculations, as well as the subsequent application of all-atom MD simulations and physical-chemistry based free energy calculations to elucidate the most favorable binding mode of the ligand in complex with the receptor. In this chapter, we provide step-by-step instructions on how to computationally investigate the binding of small-molecule ligands to protein receptors by examining as control and test cases, respectively, the binding of L-serine and R-3,4-dihydroxymandelic acid (R-DHMA) to the Escherichia coli chemoreceptor Tsr. Similar computational strategies can be used for the molecular modeling of a series of ligand:protein receptor interactions.

Entities:  

Keywords:  3,4-Dihydroxymandelic acid (DHMA); Chemoattractants; Chemoreceptor Tsr; Molecular docking; Molecular dynamics simulations

Mesh:

Substances:

Year:  2018        PMID: 29429104     DOI: 10.1007/978-1-4939-7577-8_28

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Molecular Mechanism for Attractant Signaling to DHMA by E. coli Tsr.

Authors:  Asuka A Orr; Jingyun Yang; Nitesh Sule; Ravi Chawla; Kenneth G Hull; Mingzhao Zhu; Daniel Romo; Pushkar P Lele; Arul Jayaraman; Michael D Manson; Phanourios Tamamis
Journal:  Biophys J       Date:  2019-11-27       Impact factor: 4.033

2.  Isoflavones as Ah Receptor Agonists in Colon-Derived Cell Lines: Structure-Activity Relationships.

Authors:  Hyejin Park; Un-Ho Jin; Asuka A Orr; Stephanie P Echegaray; Laurie A Davidson; Clinton D Allred; Robert S Chapkin; Arul Jayaraman; Kyongbum Lee; Phanourios Tamamis; Stephen Safe
Journal:  Chem Res Toxicol       Date:  2019-10-29       Impact factor: 3.739

3.  Activation of COUP-TFI by a Novel Diindolylmethane Derivative.

Authors:  Kyungsil Yoon; Chien-Cheng Chen; Asuka A Orr; Patricia N Barreto; Phanourios Tamamis; Stephen Safe
Journal:  Cells       Date:  2019-03-07       Impact factor: 6.600

4.  Virtual Screening of Chemical Compounds for Discovery of Complement C3 Ligands.

Authors:  Rohith R Mohan; Mark Wilson; Ronald D Gorham; Reed E S Harrison; Vasilios A Morikis; Chris A Kieslich; Asuka A Orr; Alexis V Coley; Phanourios Tamamis; Dimitrios Morikis
Journal:  ACS Omega       Date:  2018-06-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.